We use cookies on this site to enhance your user experience and to remember your preferences. By continuing to browse our website, you are agreeing to our use of cookies. To find out more about these cookies, click here.
|
For the three months ended |
For the years ended |
||||
|---|---|---|---|---|---|
|
(In millions of canadian dollars, except per share amounts or as otherwise noted) |
Sept. 30 |
June 30 |
Sept. 30 |
December 31 |
December 31 |
|
Revenues(1) |
12,787 | 11,360 | 10,931 | 49,987 | 49,122 |
|
Net earnings attributable to common shareholders |
523 | 658 | 463 | 1,717 | 1,919 |
|
Net earnings per common share |
0.74 | 0.92 | 0.65 | 2.41 | 2.69 |
|
Adjusted net earnings attributable to common shareholders(2, 3) |
578 | 658 | 465 | 2,135 | 2,136 |
|
Adjusted net earnings per common share(2, 3) |
0.81 | 0.92 | 0.65 | 2.99 | 2.99 |
|
Dividends declared per common share |
0.4330 | 0.4330 | 0.4125 | 1.65 | 1.57 |
|
Consolidated assets(4) |
448,524 | 450,419 | 426,697 | 440,224 | 418,407 |
|
Shareholders' equity |
21,291 | 21,267 | 20,369 | 20,513 | 19,481 |
|
Book value per common share |
25.85 | 25.82 | 24.58 | 24.77 | 23.69 |
|
Common shares outstanding (in millions) |
714.1 | 714.0 | 713.5 | 713.9 | 713.3 |
(1) Comparative figures for 2017 have been adjusted as a result of IFRS 15 as described in Note 3 to the Corporation's September 30, 2018 consolidated interim financial statements.
(2) Adjusted net earnings attributable to common shareholders and adjusted net earnings per common share are non-IFRS financial measures. Refer to the "Non-IFRS Financial Measures and Presentation" section of the Corporation's most recent Management's Discussion and Analysis for the definition of non-IFRS financial measures and their reconciliation with IFRS financial measures.
(3) Comparative figures for 2016 have been adjusted to reflect Other items reported by Lifeco.
(4) Comparative figures have been retrospectively adjusted as described in Note 16 to the Corporation's December 31, 2017 consolidated financial statements.
|
As at and for the years ended December 31 [in millions of Canadian dollars, except as otherwise noted] |
2017 |
2016 |
2015 |
2014 |
2013 |
|---|---|---|---|---|---|
|
Consolidated Balance Sheets |
|||||
|
Cash and cash equivalents |
5,321 |
4,396 | 4,188 | 3,989 |
4,344 |
|
Total assets(1) |
440,224 |
418,407 | 417,630 | 373,843 |
341,682 |
|
Shareholders’ equity(2) |
20,513 |
19,481 | 19,473 | 16,942 |
15,916 |
|
Consolidated Statements of Earnings |
|||||
|
Revenues |
|||||
|
Premium income, net(3) |
33,880 |
31,125 | 24,501 | 21,222 |
20,236 |
|
Investment income, net |
7,610 |
10,203 | 4,319 | 13,563 |
2,661 |
|
Fee income(3) |
8,497 |
7,794 | 7,692 | 6,990 |
5,933 |
|
49,987 |
49,122 | 36,512 | 41,775 |
28,830 |
|
|
Expenses |
|||||
|
Total paid or credited to policyholders |
35,643 |
34,675 | 22,842 | 29,160 |
17,811 |
|
Commissions(3) |
3,712 |
3,590 | 3,133 | 2,901 |
2,590 |
|
Operating and administrative expenses(3) |
7,002 |
6,380 | 5,883 | 5,162 |
4,474 |
|
Financing charges |
432 |
412 |
413 |
413 |
400 |
|
|
46,789 |
45,057 | 32,271 | 37,636 |
25,275 |
|
3,198 |
4,065 | 4,241 | 4,139 |
3,555 |
|
|
Share of earnings (losses) of investments in jointly controlled corporations and associates |
200 |
(98) | 224 | 211 |
134 |
|
Earnings before income taxes |
3,398 |
3,967 | 4,465 | 4,350 |
3,689 |
|
Income taxes |
584 |
581 | 679 | 834 |
678 |
|
Net earnings |
2,814 |
3,386 | 3,786 | 3,516 |
3,011 |
|
Attributable to |
|||||
|
Non-controlling interests |
964 |
1,343 | 1,337 | 1,248 |
984 |
|
Perpetual preferred shareholders |
133 |
124 | 130 | 132 |
131 |
|
Common shareholders |
1,717 |
1,919 | 2,319 | 2,136 |
1,896 |
|
2,814 |
3,386 | 3,786 | 3,516 |
3,011 |
|
|
Per share |
|||||
|
Net earnings attributable to common shareholders |
2.41 |
2.69 | 3.25 | 3.00 |
2.67 |
|
Adjusted net earnings(4) attributable to common shareholders(5, 6) |
2.99 |
2.99 | 3.14 | 2.96 |
2.40 |
|
Dividends declared on common shares |
1.65 |
1.57 |
1.49 |
1.40 |
1.40 |
|
Book value at year-end(2) |
24.77 |
23.69 | 23.69 | 20.18 |
18.51 |
|
Market price (Common shares) |
|||||
|
High |
37.00 |
34.70 | 38.78 | 36.70 |
36.79 |
|
Low |
31.91 |
29.02 | 30.28 | 30.14 |
27.02 |
|
Year-end |
34.54 |
33.56 | 31.81 | 36.18 |
36.00 |
(1) Comparative figures have been retrospectively adjusted as described in Note 16 to the Corporation's December 31, 2017 consolidated financial statements.
(2) Comparative figures for 2015 have been retrospectively adjusted.
(3) Comparative figures for 2017 have been adjusted as a result of IFRS 15 as described in Note 3 to the Corporation's June 30, 2018 consolidated interim financial statements.
(4) Previously described as operating earnings.
(5) Adjusted net earnings attribuable to participating shareholders and adjusted net earnings per participating share are non-IFRS financial measures. Refer to the "Non-IFRS Measures and Presentation" section of the Corporation's most recent Management's Discussion and Analysis for the definition of non-IFRS financial measures and their reconciliation with IFRS financial measures.
(6) Comparative figures for 2016 have been adjusted to reflect other items reported by Lifeco.